Skip to content

Safety and efficacy of metabolic surgery in patients with recurrent hyperlipidemia-induced acute pancreatitis

Safety and efficacy of metabolic surgery in patients with recurrent hyperlipidemia-induced acute pancreatitis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027061
Enrollment
Unknown
Registered
2019-10-30
Start date
2020-01-01
Completion date
Unknown
Last updated
2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia-induced acute pancreatitis

Interventions

Metabolic surgery group:Metabolic surgery
Conservative treatment group:conventional treatment of internal medicine

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosis of recurrent hyperlipidemia Acute pancreatitis: two or more acute pancreatic attacks induced by hyperlipidemia, accompanied by symptoms of abdominal pain, serum amylase greater than 500 U / L, abdominal imaging suggests pancreatic increase Big; 2. The BMI is greater than 27.5 kg/m2; 3. Measuring serum triglyceride levels: at least greater than 2.3 mmol / L; 4. Adapt to general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Exclude hereditary hyperlipidemia acute pancreatitis; 2. Have undergone bariatric surgery or other complicated abdominal surgery; 3. Other patients with poor medical control; 4. Drug addiction or suffering from mental disorders that are difficult to control; 5. Those who are not expected to be realistic or unwilling to bear the risk of surgery for surgery; 6. Can not cooperate with postoperative diet and lifestyle changes, poor compliance; 7. Poor general condition, difficult to tolerate general anesthesia or surgery; 8. biliary system stones or other diseases; 9. The pancreatitis was overeating before the onset of the pancreatitis, drinking a lot; 10. Pancreatic diseases: including tumors, stones, pancreatic duct stenosis, etc.; 11. Any operation that has received general anesthesia within 6 weeks prior to the signing of the ICF; 12. Pregnancy.

Design outcomes

Primary

MeasureTime frame
Hyperlipidemia-induced actue pancreatitis recurrence rate;

Secondary

MeasureTime frame
Blood lipid level;

Countries

China

Contacts

Public ContactYixing Ren

Affiliated Hospital of North Sichuan Medical College

cra0009@163.com+86 13990783731

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026